Accès à distance ? S'identifier sur le proxy UCLouvain
Safety and efficacy of [Y-90-DOTA,Tyr(3)]-octreotide (Y-90-SMT487; OctreoTher) peptide receptor radionuclide therapy (PRRT). Preliminary results of a phase-1 study
Primary tabs
| Document type | Communication à un colloque (Conference Paper) – Abstract, Présentation orale avec comité de sélection |
|---|---|
| Publication date | 2001 |
| Language | Anglais |
| Journal information | "European journal of nuclear medicine" - Vol. 28, no. 8, p. 1025-1025 (2001) |
| Peer reviewed | yes |
| issn | 0340-6997 |
| Publisher | Springer-verlag (New York) |
| Affiliations |
UCL
- Cliniques universitaires Saint-Luc UCL - MD/MINT - Département de médecine interne |
| Links |
| Bibliographic reference | Valkema, R ; Jamar, François ; Pauwels, Stanislas ; Bakker, WH ; Norenberg, J ; et. al. Safety and efficacy of [Y-90-DOTA,Tyr(3)]-octreotide (Y-90-SMT487; OctreoTher) peptide receptor radionuclide therapy (PRRT). Preliminary results of a phase-1 study.In: European journal of nuclear medicine, Vol. 28, no. 8, p. 1025-1025 (2001) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/61918 |